Cristina Perez

Cefepime plus amikacin versus piperacillin-tazobactam plus amikacin for initial antibiotic therapy in haematology patients with febrile neutropenia: results of an open, randomized, multicentre trial.

M. Sanz, A. Julià, J. Lahuerta, 2002, The Journal of antimicrobial chemotherapy.

Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia.

Marcos González, J. S. San Miguel, J. Rodríguez, 2009, Blood.

is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML)

J. Miguel, N. Puig, J. Rodríguez, 2020 .

BAALC is an important predictor of refractoriness to chemotherapy and poor survival in intermediate-risk acute myeloid leukemia (AML)

Marcos González, N. Puig, C. Santamaria, 2010, Annals of Hematology.

FlowCT for the analysis of large immunophenotypic data sets and biomarker discovery in cancer immunology

H. Goldschmidt, N. Puig, P. Tassone, 2021, Blood advances.

Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma

J. San Miguel, J. Martinez-Climent, F. Prósper, 2023, Nature Medicine.

Circulating tumor and immune cells for minimally invasive risk stratification of smoldering multiple myeloma.

H. Goldschmidt, F. Prósper, A. Órfão, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

High FOXO3a expression is associated with a poorer prognosis in AML with normal cytogenetics.

Marcos González, J. S. San Miguel, J. Rodríguez, 2009, Leukemia research.

A machine learning model based on tumor and immune biomarkers to predict undetectable MRD and survival outcomes in multiple myeloma.

N. Puig, M. Calasanz, A. Oriol, 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.